Activated Recombinant Human Factor VII
Activated Recombinant Human Factor VII Uses, Dosage, Side Effects, Food Interaction and all others data.
Activated Recombinant Human Factor VII has been used in trials studying the prevention and treatment of Haemophilia A, Haemophilia B, Congenital Bleeding Disorder, Haemophilia B With Inhibitors, and Haemophilia A With Inhibitors.
| Trade Name | Activated Recombinant Human Factor VII |
| Generic | Eptacog alfa pegol (activated) |
| Eptacog alfa pegol (activated) Other Names | Activated Recombinant Human Factor VII, Long Acting, Eptacog alfa pegol (activated) |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here Activated Recombinant Human Factor VII
